Featured
Solaris Reports Net Loss of €56 Million
Personnel costs at Solaris SE alone rose by about €11 million. The number of employees in the entire group, including the British competitor Contis acquired in 2021, rose from about 425 to a total of 800. Personnel costs therefore increased by a total of 75 percent to around €70 million. The company’s revenue increased by 30 percent to €130 million last year.
Higher costs are weighing on Solaris’ earnings: the Berlin-based fintech company posted a net loss of €56 million last year, an increase of about 33 percent compared to 2021, the company announced Tuesday.
“The year 2022 has put Solaris to a tough test,” the statement said. Increased personnel costs and costs to process Bafin orders were the main factors here. During an audit in 2020, the financial supervisory authority identified deficiencies at Solaris, some of which were serious. As a result, it sent a special auditor to the bank and also increased the capital requirements.
Read more about solaris and find other important financial news with the Born2Invest mobile app.
Bafin then tightened its control of Solaris at the beginning of January
Since then, the company has had to get the green light from Bafin before it can take on new customers.
“Decisive for the increased costs are investments to remedy regulatory deficiencies, such as consulting costs or additional personnel expenses in the double-digit million range,” a Solaris spokesman said.
Personnel costs at Solaris SE alone rose by about €11 million. The number of employees in the entire group, including the British competitor Contis acquired in 2021, rose from about 425 to a total of 800. Personnel costs therefore increased by a total of 75 percent to around €70 million. The company’s revenue increased by 30 percent to €130 million last year.
Solaris enables other startups to use the institute’s banking license and do their first business with it. The fintech also offers banking services to established companies, such as issuing credit cards.
Despite rising costs, the company says it continues to approach the profitability threshold – at least adjusted for one-time costs, such as for the ongoing restructuring or the consequences of the Bafin special audit, Solaris CEO Carsten Höltkemeyer told industry portal Finance Forward.
New financing round completed
In January, Höltkemeyer had already announced in an interview with Handelsblatt that the company should “demonstrate profitable growth and be in the black for the first time this year”.
Fresh capital is also expected to help. As the Berlin fintech company also announced, it was able to close a new financing round.
In total, Solaris is raising €38 million from existing investors – and, according to its own information, still comes to a valuation of €1.6 billion. The funds will be used, among other things, to improve governance and compliance.
Solaris also announced a reorganization of the board of directors. Chloé Mayenobe, the current head of organization, will leave the company at the end of the month. The position will not be filled. Instead, CEO Höltkemeyer will take over a large part of Mayenobe’s responsibilities himself.
__
(Featured image by PeterDargatz via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Handelsblatt, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
-
Crypto1 hour ago
Bitcoin ETF Options Debut in the U.S.: Is a New All-Time High on the Horizon?
-
Biotech2 weeks ago
Leitat Purchases ReadyCell through MedTech Innovation on Advanced Medicine
-
Fintech6 days ago
Metadev3 Now Becomes a Validator on Tezos